Guojiang Wei
机构:Renji Hospital · ORCID:0009-0003-8766-0174
发表论文 6 篇 · 总被引 101 次 · h-index 5
代表论文
- Drug‐Loaded Bacillus Calmette–Guérin Bacteria for Immuno‐Chemo Combo Therapy in Bladder Cancer (2024 · Advanced Materials · 被引 39)
- SREBF1-based metabolic reprogramming in prostate cancer promotes tumor ferroptosis resistance (2025 · Cell Death Discovery · 被引 28)
- Effect of renal sympathetic denervation on ventricular and neural remodeling (2018 · Herz · 被引 17)
- Single-cell sequencing revealed metabolic reprogramming and its transcription factor regulatory network in prostate cancer (2024 · Translational Oncology · 被引 12)
- Causal relationship between anti-inflammatory drugs and cancer: a pan-cancer study with Mendelian randomization (2024 · Frontiers in Genetics · 被引 5)
- Rapid establishment of KRAS-driven bladder cancer initiation and immune escape models using genetically engineered mice and organoid approaches (2026 · Frontiers in Immunology)